Tag : UK

CCT Impact

Khiron Receives Accreditation for UK Medical Cannabis Education and Partners with UK’s Cellen Therapeutics to Improve Clinician Education

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce it has received UK Continuing Professional Development (“CPD”) accreditation for Khiron Academy, the Company’s global medical cannabis education platform. Additionally, following its accreditation,......
CCT Impact

Khiron Expands Product Offering in UK and Increases Patient Access

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to provide an operational update with regards to its supply of EU-GMP medical cannabis products to the UK. To help alleviate bottlenecks and stock outs,......
CCT Impact

The UK Medicinal Cannabis Market Continues to Grow, Notes Ananda Developments

CCT IMPACT Agent
Medicinal cannabis continues to get traction in the UK, with the launch by Sapphire Clinics of reduced appointment costs for patients contributing to the UK’s real-world evidence base. This is a welcome initiative to increase the number of patients who can get access to medicinal cannabis. Ananda continues to work towards......